Advertisement

Topics

Latest "Foster Wheeler Inc." News Stories

17:12 EST 11th December 2018 | BioPortfolio

Here are the most relevant search results for "Foster Wheeler Inc." found in our extensive news archives from over 250 global news sources.

More Information about Foster Wheeler Inc. on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about Foster Wheeler Inc. for you to read. Along with our medical data and news we also list Foster Wheeler Inc. Clinical Trials, which are updated daily. BioPortfolio also has a large database of Foster Wheeler Inc. Companies for you to search.

Showing "Foster Wheeler" News Articles 1–25 of 476

Tuesday 11th December 2018

BIO Applauds Bipartisan 2018 Farm Bill

Bill includes key provisions that foster biotech innovation; support rural communities; and strengthen America’s bio-based economy Biotechnology Innovation Organization (BIO) President & CEO James C. Greenwood today issued the following statement on the 2018 Farm Bill: “BIO applauds the Farm Bill Conference Committee, led by Senators Pat ...


Fusion Fund Launches

Northeast Ohio-based Venture Capital Fund Aims to Increase Regional Growth and Opportunity Bounce Innovation Hub, Acquire Investments and JumpStart Inc. announce the launch of Fusion Fund, a $20-million, for-profit venture capital fund aimed at growing companies in and around Ohio. The fund offers seed and early-stage investment for advanced m...

Centene Corp CNC Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 09112018] Prices from USD $250

SummaryCentene Corp Centene is a healthcare service provider that offers services to government sponsored healthcare programs with focus on underinsured and uninsured individuals. It provides health plans through Medicaid, Medicare and Health Insurance Marketplace contracts; and other health solutions through its specialty services companies. It provides a comprehensive range of managed healthcare...


Monday 10th December 2018

Personal Health: How to Foster Empathy in Children

Research shows that we are each born with a given number of neurons that participate in an empathetic response. But early life experience shapes how we act on it.

Roche Vet O’Day Tapped To Shape Gilead’s Future As Hep C Sales Fall

Daniel O’Day, a veteran executive from Swiss pharma giant Roche, has been tapped for one of the top jobs in biotech. He’s been named the CEO of Gilead Sciences (NASDAQ: GILD), which is searching for a new direction after the quick rise and fall of a once-lucrative business for hepatitis C medicines. The Foster City, […]

Perspectives: Until Fentanyl Flow From China Ceases, Deaths Will Mount; Enforce Laws To Help Kids In Foster Care

Opinion writers weigh in on issues stemming from the opioid crisis.

Teleflex Announces Expanded “Family-Friendly” Benefits Beginning January 1, 2019 to Meet the Diverse Needs of Its Employees

Child-Bearer Parental Leave Support expanded by 300%, from 6 Weeks to 18 Weeks New Secondary Parental Caregiver Policy Introduced, with 12 Weeks Support to Secondary Caregiver (Biological, Adoptive, Surrogacy or Foster Parent) Regardless of Gender, Sexual Orientation, or Pay Classification New Infertility Managed Care Program withi...

Gilead Sciences Appoints Roche Executive Daniel O'Day As Chairman And CEO

FOSTER CITY (dpa-AFX) - Gilead Sciences Inc. (GILD) said Monday that it appointed Daniel O'Day Chairman of the Board and Chief Executive Officer, effective March 1, 2019. The company also appointe...

Gilead Sciences Names Daniel O’Day Chairman and Chief Executive Officer

-- Mr. O’Day Brings Global Pharmaceutical Leadership Experience Across Geographies and Therapeutic Areas -- -- Appointment Effective March 1, 2019 -- Gilead Sciences, Inc. (Nasdaq: GILD) announced today that its Board of Directors has named Daniel O’Day Chairman of the Board and Chief Executive Officer, effective March 1, 2019. Mr. O’Day...

Sunday 9th December 2018

WSJ: Gilead Sciences Plans To Appoint Roche Executive Daniel O'Day As CEO

FOSTER CITY (dpa-AFX) - Gilead Sciences Inc. (GILD) is planning to appoint Daniel O'Day to take the helm and help the drug company revive sales and recover from a disappointing deal, the Wall Stre...

Friday 7th December 2018

Master Facialist Angela Caglia Introduces her Lavish and Restorative Rose Quartz Goddess Facial

"Hollywood Glow Girl" Celebrity Facialist Angela Caglia launches rose quartz crystal facial with over 1000 hand-woven stones for the ultimate luxurious Bel-Air spa experience. LOS ANGELES (PRWEB) December 07, 2018 Skincare trailblazer and Master Facialist to a client roster that includes Sting, Helena Christensen, Minnie Driver and Erin and Sarah Foster, Parisian trained esthetician Ang...

Thursday 6th December 2018

Daylight Detox & Recovery Center Shines as a Light of Hope this Holiday Season for Children in Need

WEST PALM BEACH, Fla. (PRWEB) December 06, 2018 Daylight Detox & Recovery Center is giving back this holiday season by partnering with “Speak Up for Kids Palm Beach”. The nonprofit serves 1500 children countywide who are in the foster care system. Daylight not only works to break the stig...

Hidden Hearing - Giving Back to Locals This Christmas

In recognition of the cognitive decline associated with even mild hearing loss, Hidden Hearing is donating £3 for every hearing test undertaken in December to their charity of choice, Alzheimer’s Research UK, one of the UK’s leading Alzheimer’s research charities. “We would encourage everyone over the age of 55 to get their hearing tested...

Sarasota Artist and All Star Children’s Foundation to Collaborate on Custom Painting for New Foster Home Campus

Meg Krakowiak, award-winning Sarasota artist, will donate a custom painting to the All Star Children’s Foundation new foster home campus. SARASOTA, Fla. (PRWEB) December 06, 2018 Meg Krakowiak, award-winning Sarasota artist, will donate a custom painting to the All Star Children’s Foundation Campus of Hope & Healing. Known for “Art that Brings Happiness into Homes,”

Wednesday 5th December 2018

New Vitae Co-Founder Reappointed to Philadelphia Mayor’s Commission on People with Disabilities

Adam Devlin will help shape policies that foster inclusion of those with disabilities LIMEPORT, Pa. (PRWEB) December 05, 2018 Adam Devlin, co-founder and owner of New Vitae Wellness and Recovery, has been reappointed to serve on Philadelphia Mayor James F. Kenney’s Commission on People with Disabilities. The commission focuses on creating policies that support inclusion of those who identify wi...

Top Digital Health Trends That Are Driving the U.S. Healthcare Industry | Quantzig

Quantzig, a real-world evidence analytics solutions provider, has announced the completion of their latest article on the top digital health trends that are driving the U.S. healthcare industry. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20181205005457/en/

BAYADA Home Health Care Named a Best Place to Work for 2019, a Glassdoor Employees’ Choice Award Winner

This marks the company’s second year on the Best Places to Work list, which is developed solely on the input of employees. BAYADA Home Health Care has been honored with a Glassdoor Employees’ Choice Award, recognizing the Best Places to Work in 2019. The Employees’ Choice Awards program, now in its 11th year, is based solely on the input of emplo...

Public Health Roundup: Easier Foster Care Guidelines; First Baby Born Via Uterus Transplant From Deceased Donor

As foster systems are strained across the country with an influx of children whose guardians have been effected by the opioid crisis, advocates are hopeful that new guidelines will make it easier to find them homes. Meanwhile, doctors are reporting the first successful birth of a baby that was carried via a uterus transplant from a deceased donor. In other public health news: how much sleep is too...

Tuesday 4th December 2018

BionorthTX Names Entrepreneurial President and Chief Executive Officer

BionorthTX today announced that its Board of Directors has appointed Jorge Varela as President and Chief Executive Officer. He will assume day-to-day leadership of the association which represents the life sciences industry for 26 counties in North Texas including Dallas, Fort Worth, and Arlington. Dr. Terry Foster, who had been serving as Interim...

John Muir Health Receives $1 Million Grant from CARESTAR Foundation for Violence Intervention Program

John Muir Health Foundation announced that it has received a significant first-time grant issued by the CARESTAR Foundation (CARESTAR). Funds will expand John Muir Health’s comprehensive violence prevention program known as “Beyond Violence.” Launched in 2010, Beyond Violence is a hospital-based youth violence intervention program for trauma...

Mperia Therapeutics Adds Experts in Drug Delivery, Dry AMD & Atherosclerosis to CAB

CEO & President Paul Chipperton is pleased to announce today the appointment of Dr Daniel Saban, PhD; Dr Szilard Voros PhD, MD; and Dr Jean-Christophe Leroux, PhD; to the company’s Clinical Advisory Board (CAB). He commented “all three bring complementary applied Ophthalmology, Cardiovascular, and Drug Delivery expertise respectively to the clinica...

Gilead Sciences: China Approves Descovy For Treatment Of HIV-1 Infection

FOSTER CITY (dpa-AFX) - Gilead Sciences Inc. (GILD) announced that the China National Medical Products Administration or NMPA has approved Descovy ---emtricitabine 200 mg/tenofovir alafenamide 10 ...

China’s National Medical Products Administration Approves Harvoni® (Ledipasvir/Sofosbuvir) for Treatment of Chronic Hepatitis C Virus Genotype 1-6

--Harvoni Offers Highly Effective, Short-Duration, Pan-Genotypic Treatment for Chinese Patients with HCV Infection-- --Harvoni Achieved Cure Rate (SVR12) of 100 Percent in Clinical Trial of Chinese Patients with Genotype 1-- Gilead Sciences, Inc. (NASDAQ: GILD) announced today that the National Medical Products Administration (NMPA) has approv...

Monday 3rd December 2018

Kite Announces Updated Data From ZUMA-3 Study of KTE-X19 in Adult Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia

-- Ongoing Phase 1/2 Study Continues to Demonstrate High Rates of Response to a Single Infusion of KTE-X19 in a Patient Population with Limited Treatment Options -- -- Based on these Data, the Phase 2 Portion of ZUMA-3 is Now Enrolling -- -- Findings Presented in an Oral Session at the Annual Meeting of the American Society of...

Gilead Sciences Announces Recipients of Asia Rainbow Grants Program

-- Grants Program Supports Projects that Engage Young Adults and Communities Affected by HIV/AIDS --  -- Recipients Include Non-profit Organizations From Across 10 Asian Markets -- HONG KONG, Dec. 3, 2018 /PRNewswire/ -- Gilead Sciences, Inc. today announced the recipients of the Gilead Asia Rainbow Grants program. Launched in September of this year, ...


Advertisement
Quick Search
Advertisement
Advertisement

 

News Quicklinks